Lung Cancer Drugs Market Research Reports

Global Lung Cancer Partnering 2012 to 2018 - Product Thumbnail Image

Global Lung Cancer Partnering 2012 to 2018

  • Report
  • 150 Pages
From
Global Non-Small Cell Lung Cancer Partnering 2012 to 2018 - Product Thumbnail Image

Global Non-Small Cell Lung Cancer Partnering 2012 to 2018

  • Report
  • 150 Pages
From
Non-Small Cell Lung Cancer Therapeutics in Asia-Pacific Markets to 2023 - Launch of Premium Targeted Therapies and Increasing Prevalence to Drive the Market - Product Thumbnail Image

Non-Small Cell Lung Cancer Therapeutics in Asia-Pacific Markets to 2023 - Launch of Premium Targeted Therapies and Increasing Prevalence to Drive the Market

  • Report
  • 161 Pages
From
Herceptin (Trastuzumab) Biosimilar Clinical Trial Insight - Product Thumbnail Image

Herceptin (Trastuzumab) Biosimilar Clinical Trial Insight

  • Clinical Trials
  • 85 Pages
From
Non-Small Cell Lung Cancer Therapeutics in Major Developed Markets to 2021 - Emergence of Immunotherapies Drives Market Growth and Creates A Competitive Second-Line - Product Thumbnail Image

Non-Small Cell Lung Cancer Therapeutics in Major Developed Markets to 2021 - Emergence of Immunotherapies Drives Market Growth and Creates A Competitive Second-Line

  • Report
  • 113 Pages
From
Hepatocyte Growth Factor (Hepatopoietin A or Scatter Factor or HGF) - Pipeline Review, H2 2018 - Product Thumbnail Image

Hepatocyte Growth Factor (Hepatopoietin A or Scatter Factor or HGF) - Pipeline Review, H2 2018

  • Drug Pipelines
  • 73 Pages
From
CAS 95058-81-4 Gemcitabine Chemical World Report - Product Thumbnail Image

CAS 95058-81-4 Gemcitabine Chemical World Report

  • Report
  • 2134 Pages
CAS 949023-16-9 Paclitaxel side chain acid Chemical World Report - Product Thumbnail Image

CAS 949023-16-9 Paclitaxel side chain acid Chemical World Report

  • Report
  • 2027 Pages
CAS 59-05-2 Methotrexate Chemical World Report - Product Thumbnail Image

CAS 59-05-2 Methotrexate Chemical World Report

  • Report
  • 2111 Pages
CAS 6055-19-2 Cyclophosphamide monohydrate Chemical World Report - Product Thumbnail Image

CAS 6055-19-2 Cyclophosphamide monohydrate Chemical World Report

  • Report
  • 2001 Pages
CAS 63717-27-1 Amifostine hydrate Chemical World Report - Product Thumbnail Image

CAS 63717-27-1 Amifostine hydrate Chemical World Report

  • Report
  • 2066 Pages
CAS 71486-22-1 Vinorelbine Chemical World Report - Product Thumbnail Image

CAS 71486-22-1 Vinorelbine Chemical World Report

  • Report
  • 2151 Pages
CAS 7413-34-5 Sodium methotrexate Chemical World Report - Product Thumbnail Image

CAS 7413-34-5 Sodium methotrexate Chemical World Report

  • Report
  • 2006 Pages
CAS 865-21-4 Vinblastine Chemical World Report - Product Thumbnail Image

CAS 865-21-4 Vinblastine Chemical World Report

  • Report
  • 2016 Pages
CAS Vinblastine World Consumption Report - Product Thumbnail Image

CAS Vinblastine World Consumption Report

  • Report
  • 2168 Pages
CAS 119413-54-6 Topotecan hydrochloride Chemical World Report - Product Thumbnail Image

CAS 119413-54-6 Topotecan hydrochloride Chemical World Report

  • Report
  • 2195 Pages
CAS 117091-64-2 (122332-48-3) Etoposide phosphate Chemical World Report - Product Thumbnail Image

CAS 117091-64-2 (122332-48-3) Etoposide phosphate Chemical World Report

  • Report
  • 2099 Pages
CAS 20537-88-6 Amifostine Chemical World Report - Product Thumbnail Image

CAS 20537-88-6 Amifostine Chemical World Report

  • Report
  • 2004 Pages
CAS 107868-30-4 Exemestane Chemical World Report - Product Thumbnail Image

CAS 107868-30-4 Exemestane Chemical World Report

  • Report
  • 2135 Pages
Global and Chinese Capecitabine Fumarate Industry, 2018 Market Research Report - Product Thumbnail Image

Global and Chinese Capecitabine Fumarate Industry, 2018 Market Research Report

  • Report
  • 145 Pages
From
Loading Indicator

Lung cancer is the most common cause of cancer-related death in men and women around the world, accounting for well over a million deaths every year. Unsurprisingly therefore, keen competition exists among the world’s leading pharmaceuticals and niche players. The Lung Cancer Section features expert reports exploring markets and the competitive landscape for drugs, therapeutics, medical technologies, biomarkers, etc. worldwide; the epidemiology of lung cancer including risk factors and current/future mortality rates; as well as disease specific reports featuring advanced lung cancer, small-cell lung cancer and non-small-cell lung cancer. Whether you are looking to invest or expand into the lung cancer pharmaceutical market, sourcing a new provider or simply looking for the latest market data, your search begins here… Show Less Read more

adroll